Targeting BCL-XL in fibrolamellar hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma

Published:2022-09-08 Issue:17 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Shebl Bassem,Ng Denise,Lalazar Gadi,Rosemore Carly,Finkelstein Tova M.,Migler Rachael D.,Zheng Guangrong^ORCID,Zhang Peiyi,Jiang Caroline S.^ORCID,Qureshi Adam,Vaughan Roger,Yarchoan Mark^ORCID,de Jong Ype P.^ORCID,Rice Charles M.,Coffino Philip^ORCID,Ortiz Michael V.^ORCID,Zhou Daohong,Simon Sanford M.^ORCID

Funder

National Cancer Institute

National Institutes of Health

Robertson Therapeutic Development Fund

Leona M. and Harry B. Helmsley Charitable Trust

Sohn Conference Foundation

The Rally Foundation

The Bear Necessities

The Truth365

The Loundsberry Foundation

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/161820/files/pdf

Reference35 articles.

1. Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms

2. Fibrolamellar carcinoma: An entity all its own

3. DNAJB1-PRKACA is specific for fibrolamellar carcinoma

4. The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients

5. Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein isoform-centric therapeutics: expanding targets and increasing specificity;Nature Reviews Drug Discovery;2024-09-04

2. PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications;European Journal of Medicinal Chemistry;2024-09

3. A study on exosome based delivery of Terminalia chebula Retz. fruit extract in hepatocellular carcinoma;Pharmacological Research - Natural Products;2024-06

4. FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion;Frontiers in Oncology;2024-03-28

5. A preclinical “magic bullet” against fibrolamellar hepatocellular carcinoma?;Molecular Therapy;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3